AHA Urges HRSA to Abandon 340B Rebate Pilot, Warns of Severe Burdens on Hospitals

AHA General Counsel Chad Golder wrote a letter to HRSA Administrator Thomas Engels urging him to abandon the 340B rebate pilot program.
The American Hospital Association (AHA) is pushing back forcefully against the Health Resources and Services Administration’s (HRSA) new 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

A Washington, D.C. federal appeals court has extended drugmaker filing deadlines and has pushed back oral arguments in litigation surrounding HRSA's authority to approve 340B rebates.
A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in the Second Quarter of 2025, Filings Show

340B program stakeholders continued to spend big on federal lobbying efforts in the second quarter of 2025.
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Publishes New FAQ on Controversial 340B Rebate Pilot Program

HRSA recently published an FAQ addressing various stakeholder inquiries about its 340B rebate pilot program.
The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Schedules Late-October Oral Arguments for Drugmaker 340B Rebate Appeals

A Washington, D.C. federal appeals court scheduled oral arguments for drugmakers' 340B rebate appeals.
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Rejects Health System’s Bid for Interest on 340B Medicare Lump Sum Repayments

A federal district judge in Washington, D.C. ruled that an Alabama health system is not entitled to interest payments on CMS' 340B lump sum repayment remedy.
A federal judge in Washington, D.C. has rejected a University of Alabama Health System lawsuit seeking interest on Medicare’s lump [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Anti-340B Dark Money Group Promotes GOP-Passed Reconciliation Bill in New Ad

Dark money group Building America’s Future released a 30-second ad touting the new reconciliation budget law, which includes massive Medicaid spending cuts.
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live